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Theprotection ofchildren willrequire... that
guidelinesforriskassessmentaddress children.
Carcinogen Risk Assessment
Guidelines and Children
Over two years ago, the White House issued Executive Order
13045, "Protection of Children from Environmental Health Risks
and Safety Risks," which called upon federal agencies to identify
and assess environmental health and safety risks that may dispropor-
tionately affect children and to ensure that their policies, programs,
and standards address these risks (1). The executive order reflected a
growing emphasis on well-recognized differences in the exposures,
metabolism, and disease responses ofinfants and children to chemi-
cal exposures.
Concern about the special vulnerability ofinfants and children
to environmental exposures, particularly pesticides, prompted the
U.S. Congress in 1988 to request that the National Academy of
Sciences study this issue. This study resulted in the important 1993
report Pesticides in the Diet ofInfants and Children (2). In its
National Agenda to Protect Children from Environmental Health
Threats, the U.S. Environmental Protection Agency (EPA) com-
mitted itself to ensuring that all standards it adopts will protect
children (3). In 1997, the EPA solicited comments from the public
on which standards to reevaluate to assess special needs ofchildren,
and a national advisory committee identified several topics-mer-
cury emissions, protection from farm chemicals, atrazine in food
and water, and organophosphate and carbamate pesticides (4).
The focus on children is reengaging the public health communi-
ty in the environmental health arena after a period ofseeming indif-
ference. This shift, coupled with a renewed emphasis on the safety of
food and water supplies, represents a renaissance for environmental
health and an important challenge. The protection of children will
require, among other things, that guidelines for carcinogen risk
assessment address children.
These concerns make the proposed revised EPA guidelines for
carcinogen risk assessment ofparticular interest. It is important to
ensure that the guidelines address cancer risks for children and to
protect children and infants. The most recent draft of the guide-
lines was issued in 1996 (5). The draft was released before adop-
tion ofthe executive order and did not include any direct mention
ofhow to assess the particular needs ofchildren. This draft remains
under review.
Federal policy has one example of a statute written with the
intent ofproviding special protections for infants and children. The
Food Quality Protection Act (FQPA) (6), passed in 1996 by a unan-
imous vote of the Congress, amended federal laws regarding pesti-
cides in two ways that were particularly important for children. First,
the statute requires that when allowable levels ofpesticides for foods
are set, special protections be provided for children. The statute rec-
ognizes that the exposure ofchildren may differ from that ofadults
and, in this case, mandates collection ofdata about food consump-
tion patterns ofchildren (section 301). It incorporates scientific prin-
ciples in mandating that all routes of exposure to pesticides be con-
sidered in assessing risk (section 405). Second, federal agencies are to
considerwhether infants and children may be disproportionately sus-
ceptible to pesticides and to consider the potential for combined
impacts ofchemicals with common
~t . rmechanisms of action. These are
important new principles for scien-
tifically grounded policy that will
be protective of children. When
data are not adequate to allow for
assessment of differences in expo-
sure and susceptibility for children,
PatriciaA.Buffler pesticide tolerances are to incorpo-
rate an additional safety factor of
10. Although the process of implementation of these fundamental
new directions may be difficult and will require adjustment both by
regulatory agencies and by pesticide users and producers, these
important policy goals are worthy ofconsideration in the context of
guidelines forriskassessment forchemical carcinogens.
Toxic responses in infants and children can differ markedly from
those seen in adults, both in severity and in the nature ofthe adverse
effect. During the growth and maturation process there is an evolu-
tion of membranes, including receptors, in infants and children as
they approach adulthood. These changes represent a potential for a
very different environment for chemical and drug interactions with
receptors. Examples of differences in drug-receptor interactions
between children and adults are provided by the paradoxical respons-
es to phenobarbital and Ritalin in children versus adults.
Phenobarbital, a sedative in adults, produces hyperactivity in chil-
dren, whereas Ritalin, which is used as an antihyperactive agent in
children, produces an opposite effect in adults. The explanation for
these widely differing responses in children and adults is believed to
reside in differences in receptor-drug interactions (7).
Differences in the developing infant and child also effect absorp-
tion, dose, distribution, biotransformation, storage, and excretion of
chemicals or drugs in the body, and therefore toxicity (7). Ofparticu-
lar interest are the enzymes involved in metabolism of toxic com-
pounds. The enzymes important to both phase I transformation
through the cytochrome P450 system andphase 2 transformation can
varywith age (8).This variability can result in differences in sensitivity
to the toxic effects of pharmacologic agents and xenobiotics.
Moreover, children mayalso have less capacity to repairdamage.
Perhaps the most distinguishing characteristic ofinfants and chil-
dren is that they grow and develop. Different systems and organs
develop at different rates and at different phases (). Children may
be more vulnerable to chemical exposures that affect growing tissue.
A critical period for exposure to radiation in the mammary gland is
the period duringadolescencewhen cells areproliferating.
Studies ofeffects ofradiation provide evidence ofincreased suscep-
tibility ofthose exposed during childhood (1J). Among the survivors
of radiation from the exploding ofthe atomic bomb, susceptibility
to leukemia was greater for those who were under 20 years of age
when exposed as compared to those who were older. Moreover, the
type of leukemia developed varied by age at exposure. For breast
cancer, risk also varied by age ofexposure and was highest for those
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who were under 20 years of age. The rate of excess risk decreased
with age up to 39 years and was significantly lower for those 40
years ofage or older when exposed. Studies ofexposure to cigarette
smoke have shown that the risk ofdying ofbreast cancer is greater
for those who started smoking before age 16 than for those who
started smoking after age 20 (11).
Issues of concern pertain to all steps in the risk assessment
process. The first step in risk assessment, hazard identification, is to
decide what agents merit detailed review. In considering whether
risk assessment approaches are protective for children, an initial
question is whether methods for hazard identification would cap-
ture the agents ofconcern for children. The major sources ofinfor-
mation for hazard identification are animal bioassays and epidemi-
ologic studies. An important question to review for carcinogen risk
assessment is whether these data sources are adequate to identify
agents that would pose particular risks for children.
Some attention has been given to this issue. One approach is to
consider expanding the scope ofprotocols for animal assays to incor-
porate perinatal exposures. As part of a 1992 conference on risk
assessment for children, it was conduded that animal bioassays which
included perinatal exposures did not detect carcinogens that were not
identified through standard methods (12). A more recent review pre-
pared by the EPA for the Science Advisory Panel, which is charged
with reviewing the scientific basis for pesticide policy, came to a dif-
ferent conclusion (13), although the analysis has not yet been
reviewed by the Science Advisory Panel. The question ofwhether
current data sources are adequate to identify agents that pose partic-
ular risks for children should be carefully considered in the develop-
mentofnewguidelines for riskassessment.
For epidemiologic studies,- additional attention to studies of in
utero, perinatal, and childhood exposure is needed. Data used for
risk assessment are often based on studies ofhealthy adult males.
Infants and children differ from adults in their exposures both
qualitatively and quantitatively, in part because they eat more food,
drink more water, and breathe more air per unit of body weight
than adults do (2). For example, the air intake ofa resting infant is
twice that ofan adult under the same conditions (9), and the activi-
ty patterns ofchildren further increase their exposure to pollutants.
Because children are typically engaged in more physical activity,
play close to the ground, and engage in characteristic hand-to-
mouth behavior, they are exposed to higher levels oftoxicants such
as pesticides, radon, and particulate matter (14). The micro- and
macroenvironments for infants and children change through devel-
opment. Additionally, these environments may vary by demograph-
icor cultural group, and these differences may influence exposure.
For exposure assessment of infants and children, their environ-
ment must be defined and their behavior must be linked to the time
spent in different environments such as home, daycare, or school
and how this varies by age. Exposure research is needed to describe
how children's typical activities and environments differ from those
of adults and what contaminant levels are associated with these
activities and environments. Currently, the data needed for expo-
sure assessment ofinfants and children are seriously lacking.
Differences in the rate of movement of a drug or chemical
through the body ofan infant or child as compared to an adult will
affect the dose rate as well as the type and degree ofadverse effects
observed. Such differences are well documented for absorption by
inhalation, ingestion, and dermal contact, and appear to be related
to differences in tissue (membrane) composition, surface area,
and/or perfusion. The composition of some membranes changes
with maturation. These differences can exert significant influences
on the quantity and rate ofabsorption ofcertain drugs and chemi-
cals. Adjustments need to be made to dose estimates to account for
differences ofinfants and children.
In the context ofcancer risk assessment, an enduring controversy
has been the approach ofextrapolating rwsults from high doses used in
animal experiments to the lower doses experienced by humans. In the
past, the risk assessment guidelines have used models that are linear in
the low dose region (which represents environmental exposure) as a
default. The EPA's approach has been to use the upper 95% confi-
dence bound on the slope ofthe line generated by the linear model to
estimate the potency ofcarcinogens. Such potencies are then used to
estimate risks at various exposures. This approach is conservative in
that it allows forvariability in response among animals and it provides
a more stable estimate than would an estimate of maximum likeli-
hood. It does not, however, incorporate any provision for particular
vulnerability ofanyhuman population (9.
One of the most important features in the proposal for new
guidelines is the incorporation ofgreater emphasis on mechanisms
for carcinogenic action. The EPA has proposed to depart from
using linearized models to relate doses to responses when the mode
of action is deemed not to be genotoxic. In these cases, the guide-
lines propose to use a benchmark dose approach to risk assessment.
A benchmark approach uses a model to determine the dose that
would result in a defined rate of an outcome, usually 5 or 10%.
Safety factors can then be applied to this benchmark dose level. This
approach does not incorporate the conservatism ofthe linear model.
A key question for development ofguidelines that address issues
ofconcern for children is how to ensure that the review ofmodes of
action identifies all those that might be relevant to children. Because
children's metabolic pathways and repair capacities are known to
differ from those of adults, it is important to develop criteria to
ensure that judgments made on modes of action reflect not just
adult metabolism but also that ofchildren. Admittedly, this will be
a difficult undertaking, as evidence for modes ofaction often comes
solely from rodents and poses difficulties of interpretation even for
adults. But before methods of assessment that are protective of
health are abandoned, we should ensure that the health ofchildren
is not beingjeopardized.
As noted, children may be more vulnerable to effects of toxic
compounds than adults receiving a comparable dose. Adjusting
dose-response parameters for additional vulnerabilities ofchildren
is also an important step.
The differences in dose, vulnerability, and mechanisms ofaction
between adults and children have not been adequately studied, and
consequently there are few data to guide this aspect of carcinogen
risk assessment for children. A recent review suggests that data are
not likely to be available to support quantitative review (15). It
would be appropriate for the new cancer risk assessment guidelines
to address when to consider the potentially greater vulnerability of
children and how this could be systematically incorporated into the
assessment. For the development of reference doses for noncancer
effects, an additional safety factor can be used to address variability
in the human population. The FQPA (6) provides for an additional
margin ofsafetywhen there is reason to believe there may be dispro-
portionate impacts on children but inadequate information to eval-
uate them quantitatively. An equivalent approach for cancer risk is
needed aswell.
Risk assessment methods for carcinogens have not considered
the timing ofdoses ofcarcinogens during a human lifetime. Models
used to estimate dose and response do not consider the age atwhich
doses are applied. A given dose ofa carcinogen counts the same at
70 years ofage as it does at 5. Because there is considerable evidence
that doses received earlier in life are more likely to result in develop-
ment ofcancer than doses received late in life, this approach would
be expected to underestimate risks of doses received during child-
hood. Moreover, recent evidence suggests that cancers experienced
early in life are associated with adult medical problems in a large
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percentage of cases. Effects of treatments typically used for cancer
can include second malignancies, organ toxicity, effects on growth,
endocrine effects, and reproductive effects (16). The new guidelines
should give serious attention to doses received earlier in life, which
can be expected to pose greater risks during the lifetime as awhole.
Currently, we simply do not have sufficient information
regarding the differences in exposure, susceptibility, and toxicity
for infants and children as compared to adults to accurately charac-
terize the risk for most chemical exposures. The implications ofthis
are manifold. We must aggressively pursue the research agenda
outlined at the EPA conference (14) while simultaneously imple-
menting policies that address the implications of the information
gaps. We have no evidence to suggest that exposure standards
based on assumptions about adult toxicity, susceptibility, and
exposure will adequately protect infants and children. Quite the
contrary, there is sufficient evidence for some agents to believe they
may not. The proposed carcinogen risk assessment guidelines
should incorporate language that will provide infants and children
with needed protection. Continued emphasis should be given to
exposure reduction.
The task ahead, to adapt the proposed carcinogen risk assess-
ment guidelines to embrace the needs of infants and children for
adequate protection, will no doubt face many challenges.
Developing the science base will require a sustained effort ofmany
disciplines, but developing the philosophic base may be equally or
more challenging. The recent focus on human rights in schools of
public health as a framework for public health ethics may provide
some guidance and support.
Human rights organizations and community-based groups
argue for the incorporation ofhuman rights standards into public
health policies. Even such fundamental human rights concepts as
the right to health and the special duty to protect vulnerable popu-
lations have not been operationally defined in public health, and
no scholarship in jurisprudence exists to describe the parameters of
these rights (17,18). Nevertheless, there is a growing bodyoflitera-
ture from which to draw in the areas ofphilosophy, public health,
and biomedical ethics (19,20). The human rights perspective is
valuable because it derives from an organized set ofinternationally
recognized and forward-thinking legal standards (21).
Advancing public health policies without seriously considering
their human rights dimensions may seriously limit their effectiveness
and, in some instances, may even result in harm to individuals (22).
While promulgating carcinogen risk assessment guidelines that do
not adequately address the special exposures, susceptibility, and vul-
nerability of infants and children would be ineffective and possibly
harmful, i.e., conveying a false sense ofprotection, it can be further
argued that it would violate basic notions ofhuman rights. All per-
sons have a right to health, induding a safe environment and protec-
tion from exposures that may undermine their health. For infants
and children, who can not act on their own behalf, a special obliga-
tion is incurred. All potentially toxic exposures to which infants and
children are exposed need to be assessed for their impact, and this
information should be incorporated in carcinogen riskassessment.
It was community-based groups that advocated effectively for
the children's environmental health agenda that is now on the table
(23). They were correct to do so. It is also community organiza-
tions that lead the way in advocating for human rights concepts in
the formulation ofpublic health policies. We will need their help
in addressing the challenges ahead.
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